Hypoplastic Left Heart Syndrome (HLHS) is a severe and rare congenital heart defect characterized by underdevelopment of the left heart structures: the left atrium, mitral valve, left ventricle, aortic valve, and ascending aorta are variably hypoplastic or atretic. This condition results in the left heart's inability to sustain systemic circulation, forcing oxygenated blood from the lungs to reach the systemic circulation through intracardiac shunts and a patent ductus arteriosus. Without timely treatment, HLHS is invariably fatal within the first days or weeks of life, making it one of the most challenging conditions in pediatric cardiology and cardiac surgery.
The definite cause of hypoplastic left heart syndrome lies in an embryological defect affecting the formation and development processes of the left heart segment. Between the fourth and seventh weeks of gestation, abnormalities in proliferation, differentiation, and migration of primitive cardiac cells lead to reduced growth of the left ventricle, mitral valve, aortic valve, and ascending aorta. These changes may originate from primary hypoplasia of the left ventricle or, more frequently, secondary to early valvular stenosis or atresia that obstructs normal antegrade flow, following the “flow-dependent” developmental model also seen in hypoplastic right heart syndrome (HRHS). In the absence of adequate blood flow through the left structures, progressive reduction in size and function of these cardiac chambers occurs.
Risk factors that increase the likelihood of HLHS include genetic, familial, and maternal factors:
The central pathogenic mechanism consists of the absence or marked reduction of antegrade flow through the mitral and/or aortic valves during fetal life. This leads to insufficient growth of the left ventricle and associated structures, promoting progressive hypoplasia of the left chambers and ascending aorta. In particular, when valvular stenosis or atresia occurs early, the left ventricle fails to develop, and systemic circulation is sustained solely by the right heart via shunts and the ductus arteriosus.
From a pathophysiological perspective, HLHS causes a critical obstruction to oxygenated blood flow from the lungs to the systemic circulation. At birth, survival depends on the presence of interatrial communications (patent foramen ovale, atrial septal defect) and a patent ductus arteriosus, which allow oxygenated blood to pass from the right heart into the aorta and then to the tissues. Closure of the ductus arteriosus causes rapid clinical deterioration, with severe cyanosis, metabolic acidosis, and circulatory collapse. Spontaneous survival is extremely limited and requires prompt identification and treatment.
Hypoplastic left heart syndrome thus represents a condition of high hemodynamic complexity, where the balance between different blood flows and the timing of diagnostic and therapeutic interventions are critical determinants of patient survival.
Hypoplastic left heart syndrome (HLHS) presents with a dramatic clinical picture within the first hours or days of life, reflecting the left heart's inability to provide adequate oxygenated blood to peripheral tissues. After a very brief period of apparent well-being, the newborn rapidly develops severe symptoms as the physiological closure of the ductus arteriosus interrupts the compensatory flow to systemic circulation.
Central cyanosis emerges as an early and persistent sign, often resistant to conventional oxygen therapy, followed by the onset of respiratory distress with tachypnea, shallow breathing, and signs of respiratory distress.
Simultaneously, pallor, profuse sweating, irritability, and progressive feeding fatigue develop, impairing nutrition and resulting in poor weight gain.
The appearance of hypothermia and lethargy indicates worsening metabolic status, while arterial hypotension with a weak pulse is the clearest sign of cardiac output failure.
The clinical course is almost always rapid and progressive: restriction or closure of the ductus arteriosus causes sudden hemodynamic worsening, with critically reduced systemic perfusion. This quickly leads to cardiovascular collapse, progressive metabolic acidosis, oliguria-anuria, and a very high risk of sudden death without urgent intervention.
On physical examination, the newborn appears frankly cyanotic, often hypoperfused and distressed.
Breathing is labored and shallow, the pulse is thready and tachycardic, while heart sounds are generally muffled due to reduced flow through hypoplastic structures.
Murmurs are variable: they may be absent in the most severe forms due to absent valvular flow, or present as a soft systolic murmur in cases of significant interatrial shunting. Hepatomegaly develops early due to systemic venous congestion, often accompanied by dependent edema and reduced urine output.
In rare cases where hypoplasia of the left structures is partial or some form of transient compensation is present, symptoms may have a slower onset, with chronic cyanosis of variable degree, easy fatigability, poor weight gain, and progressive signs of heart failure. However, even in these less acute forms, spontaneous evolution remains rapidly unfavorable without specific treatment.
Symptom progression from cyanosis and respiratory distress to circulatory collapse reflects the strict dependence of hemodynamic balance on the patency of intracardiac communications and the ductus arteriosus, underscoring the need for early diagnosis and immediate therapeutic intervention to alter the prognosis of these patients.
Diagnosis of hypoplastic left heart syndrome (HLHS) requires careful integration of clinical suspicion, instrumental assessment, and advanced imaging. Suspicion typically arises in a neonate presenting with severe cyanosis, systemic hypoperfusion, and signs of heart failure unexplained by respiratory pathology. Progressive symptoms and poor response to oxygen therapy warrant urgent cardiological evaluation.
Fetal echocardiography often enables prenatal diagnosis, visualizing hypoplasia of left heart structures and abnormal intracardiac flow. In cases undiagnosed before birth, transthoracic echocardiography (TTE) is the cornerstone exam, allowing direct assessment of hypoplasia or atresia of the left ventricle, mitral valve, aortic valve, and ascending aorta. Echocardiography also evaluates the presence, size, and function of interatrial communications, ductus arteriosus patency, and possible associated anomalies.
Electrocardiogram (ECG) may show sinus rhythm, right axis deviation, and right ventricular hypertrophy, while typical left ventricular hypertrophy is absent due to reduced muscle mass. Chest radiography may reveal a globular cardiac silhouette enlarged due to dilation of the right chambers, and increased pulmonary vascular markings in cases of excessive shunting.
In critically ill neonates or patients with complex anatomy or persistent diagnostic uncertainty, advanced imaging such as cardiac magnetic resonance imaging (CMR) or computed tomography (CT) is indicated for three-dimensional reconstruction of structures, detailed evaluation of systemic and pulmonary vessels, and surgical planning.
Cardiac catheterization is reserved for selected situations, both for measurement of intracardiac pressures and vascular resistances, and for performing palliative procedures such as balloon atrial septostomy or ductal stenting.
Differential diagnosis includes other cyanotic congenital heart diseases, particularly hypoplastic right heart syndrome, mitral valve atresia, critical aortic stenosis, and severe aortic coarctation. Accurate distinction is crucial for therapeutic strategy and prognosis.
Treatment of hypoplastic left heart syndrome is among the greatest challenges in pediatric cardiology and cardiac surgery, relying on a multidisciplinary approach at highly specialized centers. The main goal is to ensure adequate systemic blood flow and prevent circulatory collapse through a gradual and personalized therapeutic pathway.
In the neonatal phase, maintaining ductus arteriosus patency with prostaglandin E1 infusion is essential to allow oxygenated blood to reach the aorta and peripheral tissues. Ventilatory support, correction of metabolic disturbances, and intensive monitoring are often necessary to stabilize the newborn in the first hours of life. In cases of significant restriction of interatrial communications, balloon atrial septostomy may be indicated to facilitate mixing between oxygenated and venous blood.
Surgical treatment follows a three-stage approach aimed at converting the circulation from biventricular to univentricular and assigning systemic pump function to the right ventricle:
In selected cases, early heart transplantation may be considered as an alternative, particularly in the presence of unfavorable anatomy or contraindications to conventional surgical stages.
The prognosis of HLHS is closely linked to early diagnosis, residual anatomy, success of sequential surgical corrections, and absence of perioperative complications. Five- and ten-year survival rates after completion of the Fontan procedure have progressively improved over recent decades due to advances in surgery, anesthesia, and pediatric intensive care. However, quality of life may be affected by medium- and long-term complications and the need for ongoing monitoring and repeated treatments.
A prolonged multidisciplinary follow-up is essential, with surveillance of ventricular function, systemic oxygen saturation, growth, and neurodevelopmental progress, alongside prevention and management of major complications.
Hypoplastic left heart syndrome carries a high risk of complications, both in the untreated natural course and during follow-up after surgical palliation or transplantation. Prognosis depends heavily on initial anatomy, surgical success, age at correction, and presence of associated anomalies.
In the untreated natural course, main complications include progressive systemic hypoxia, acute heart failure, severe metabolic acidosis, multiorgan damage, and death within the first days or weeks of life.
Following surgical treatment or heart transplantation, significant risks remain:
Management of these complications requires constant surveillance and specialized follow-up with timely interventions for arrhythmias, organ dysfunction, nutritional issues, or thromboembolic problems, aiming to improve survival and quality of life.